Centene Raises Full-Year Earnings Guidance After Posting Unexpected Profit In Q3

In this photo illustration a Centene Corporation logo seen displayed on a smartphone with the stock market information of Centene Corporation in the background. (Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty Images)
In this photo illustration a Centene Corporation logo seen displayed on a smartphone with the stock market information of Centene Corporation in the background. (Photo Illustration by Igor Golovniov/SOPA Images/LightRocket via Getty Images)
Profile Image
Anan Ashraf·Stocktwits
Updated Mar 05, 2026   |   2:29 PM EST
Share
·
Add us onAdd us on Google
Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...
  • The company raised its full-year adjusted earnings guidance to at least $2 per share, up from its previous guidance of at least $1.75.
  • The company also said it conducted a quantitative impairment analysis in the third quarter to determine whether goodwill was impaired.
  • The analysis was completed in October, and the company recorded a non-cash goodwill impairment of $6.7 billion, it said.
     

Advertisement|Remove ads.

Centene Corporation (CNC) on Wednesday raised its full-year adjusted earnings (EPS) forecast after it posted an unexpected profit in the third quarter.

Analysts, on average, were expecting the insurer to post a loss of $0.18 per share in the third quarter, according to data from Fiscal AI. However, the company reported adjusted EPS of $0.50, sending shares rallying 10% in the premarket session.

Read Next
Loading...
Loading...

The company subsequently raised its full-year adjusted earnings guidance to at least $2 per share, up from its previous guidance of at least $1.75.

Advertisement|Remove ads.

Medical cost ratio, or the percentage of premiums used on medical care, in the three months through the end of September was 92.7%, up from the 89.2% reported in the corresponding period of 2024. The company pinned the increase to higher medical costs in the Medicaid business, among other factors. 

The company also said that it performed a quantitative impairment analysis during the third quarter to determine whether goodwill was impaired after the implementation of President Trump's tax and budget bill, as well as a decline in the company’s stock price.

The analysis was completed in October, and the company recorded a non-cash goodwill impairment of $6.7 billion, it said. 

Advertisement|Remove ads.

Get updates to this developing story directly on Stocktwits.

Comments
Share your thoughts...

Comments posted here will also appear on symbol pages.

Follow on Google News
Read about our editorial guidelines and ethics policy

Advertisement|Remove ads.